|
tbar.gif
Click
here to
submit entries
|
|
|
Survey:
Drugmakers May Scale Back R&D Investment in Britain
|
March
19, 2008--The results are in from a
survey conducted on behalf of the Association of the British
Pharmaceutical Industry and the Confederation of British Industry:
Three-quarters of more than 100 drugmakers with British operations said
they had little confidence in the current UK market environment, and 83%
expect the position to deteriorate in the coming 12 months. More than
one-third of companies expect to cut investment in R&D in Britain; a
similar number of companies will reduce investment in buildings and other
tangible assets over the coming year. The loss of confidence in the UK
market is being linked to the government’s plans to renegotiate the
Pharmaceutical Price Regulation Scheme. Reuters
|
|
|
Genstruct: Patience, Persistence, and Payoff
By John Russell |
|
Finding the right business model for systems biology (SB) technology providers has been challenging — that’s hardly a new theme in biotech.
Click
here
|
|
|
